Healthcare Facilities company Aster DM Healthcare announced Q1FY26 results Revenue for Q1FY26 grew 8% YoY to Rs 1,078 crore vs Rs 1,002 crore in Q1FY25. Operating EBITDA grew 21% YoY to Rs 215 crore in Q1FY26 vs Rs 177 crore in Q1FY25. Operating EBITDA Margins stood at 20.0% in Q1FY26 vs 17.7% in Q1FY25. Normalised PAT (Post NCI) grew 22% YoY to Rs 90 crore vs Rs 74 crore in Q1FY25. Azad Moopen, Founder and Chairman, Aster DM Healthcare, said: “Aster DM Healthcare has delivered a strong start to FY26, recording an 8% YoY growth in revenue, reaching Rs 1,078 crore. Operating EBITDA expanded by 21%, while Profit After Tax (PAT) grew by 22%, reflecting a positive trajectory in performance. Operational metrics also demonstrated positive movement by 4% year-on-year reduction in Average Length of Stay (ALOS) to 3.1 days in Q1FY26. Additionally, Average Revenue Per Occupied Bed (ARPOB) rose 14% year-on-year to Rs 50,200 in Q1FY26 underscoring enhanced efficiency and case mix improvements. The announcement of the new hospital in Bengaluru and the additional stake hike in Aster Ramesh Hospitals marks a significant milestone in Aster’s India growth journey. In line with our long-term strategy, we are making steady progress on the proposed merger with Quality Care India Ltd. (QCIL), a move that will establish the combined entity as one of the most comprehensive and integrated healthcare networks in the country. Both Aster and QCIL have delivered strong financial performance this quarter, with their respective performances complementing each other and reinforcing the significant potential for seamless integration. With these initiatives, we remain well-positioned for sustained growth and are confident that our commitment to operational excellence, clinical innovation, and strategic expansions will allow us to redefine healthcare delivery in India”. Result PDF